About this trial
Patients who underwent pulsed radiofrequency (PRF) treatment of the posterior tibial nerve under ultrasound guidance, which is routinely performed in our clinic for severe heel pain following a calcaneal fracture, were evaluated through interviews. The assessment was conducted using the Visual Analog Scale (VAS) for pain and the American Orthopaedic Foot and Ankle Society (AOFAS) score.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
History of calcaneal fracture
VAS score >5
Pain persisting for more than 3 months after the fracture
Disqualifiers
Presence of other foot pain-causing conditions (e.g., plantar fasciitis, heel spur)
Additional fractures other than the calcaneus
Pregnancy
Coagulopathy or use of antiplatelet medications
Trial design
Parallel
Treatments tested in this trial
ultrasound-guided posterior tibial nerve pulsed radiofrequency
Procedure/SurgeryThe posterior tibial nerve (PTN) was identified with a 5-12 MHz linear ultrasonography (US) probe at the level of the medial malleolus, where it runs posterior to the posterior tibial artery. Using the in-plane technique, a 22-gauge, 10-cm radiofrequency cannula was inserted under US guidance and advanced until the tip was adjacent to the nerve. Pulse radiofrequency was applied at 42°C for 240 s with a pulse width of 20 ms.
Control Group
Other interventionNo intervention
Treatment groups
Trial outcomes
Primary outcomes
Visual analog scale (VAS)
VAS is a scale that can be used measuring pain. Scores range from 0 (no pain) to 10 (the worst pain)
Secondary outcomes
The American Orthopaedic Foot and Ankle Society (AOFAS)
The American Orthopaedic Foot and Ankle Society (AOFAS) score is evaluated under three subcategories: pain, function, and alignment. It includes both objective (function and alignment) and subjective (pain) data. Patients report their pain levels, which are then scored by physicians. Additionally, patients and doctors collaborate to complete the functional and alignment assessments. Scores range from 0 to 100, with 100 representing a healthy patient. This scoring system will be assessed pre-procedure, on the day of the procedure, and at the 3-month follow-up.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.